Profile picture

Professor Heinz Drexel

Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch (Austria)
Membership: FESC Member
Follow
Biography
CURRICULUM VITAE 1976 Medical degree with highest award of the Republic of Austria, University of Innsbruck. 1983-1987 Assistant Professor, leading physician of the Diabetes inpatient and outpatient clinic, University of Innsbruck. 1991-1994 Head of Lipid Research, Division of Cardiology, Department of Medicine, University Hospital of Zurich, Switzerland. Since 1994 Professor of Medicine; 1994–2016 Head of Department of Medicine, County Hospital of Feldkirch (since 2000 designated “Academic Teaching Hospital of Feldkirch”), Austria. Since 1997: Head of the research institute VIVIT at the Academic Teaching Hospital Feldkirch, Austria Since 2006 Dean of the Medical Faculty and Full Professor of Medicine (Cardiology and Endocrinology), Private University of the Principality of Liechtenstein. 2018-2020 President of the ESC-Working Group “Cardiovascular Pharmacotherapy” Since 2020 Head of the Department of Internat Medicine & Intensive Care, County Hospital Bregenz, Austria
Logo ESC

Contributor content

Statistical issues in clinical trials
Session
Statistical issues in clinical trials
13 December 2024
Repurposing anti-diabetic pharmacotherapy: the new cure for all evils?
Session
Repurposing anti-diabetic pharmacotherapy: the new cure for all evils?
2 September 2024
Lipid management in patients with acute coronary syndrome: strike early and strong!!
Session
Lipid management in patients with acute coronary syndrome: strike early and strong!!
18 March 2022
Latest insights into cholesterol management for the post-myocardial infarction patient
Session
Latest insights into cholesterol management for the post-myocardial infarction patient
3 September 2019
PCSK9 inhibitors: from cells to patients
Session
PCSK9 inhibitors: from cells to patients
2 September 2019
How to implement PCSK9 inhibitor treatment in my practice
Session
How to implement PCSK9 inhibitor treatment in my practice
1 September 2019
PCSK9 inhibitors - For the many or the few?
Session
PCSK9 inhibitors - For the many or the few?
28 August 2018
Are generic drugs safe in heart failure ?
Session
Are generic drugs safe in heart failure ?
27 August 2018
Recent results in clinical trials of blood cholesterol lowering
Session
Recent results in clinical trials of blood cholesterol lowering
29 August 2017
Cholesteryl ester transfer protein (CETP) inhibition: emerging science in LDL lowering
Session
Cholesteryl ester transfer protein (CETP) inhibition: emerging science in LDL lowering
30 August 2016

ESC 365 is supported by